RFP Financial Group’s Globus Medical GMED Stock Holding History

RFP Financial Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41	Closed	-$2.04K	–	934
2023 Q3	$2.04K	Buy	+41	New	+$2.29K	﹤0.01%	655

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RFP Financial Group's GMED Position: Q4 2023 in Review

RFP Financial Group sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 41 shares — an estimated $2.04K sold.

RFP Financial Group first reported a position in GMED in Q3 2023 and held it in 1 quarter. The position peaked at $2.04K in Q3 2023. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

RFP Financial Group reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
RFP Financial Group sold 41 Globus Medical shares in Q4 2023, an estimated $2.04K.
RFP Financial Group first reported a position in Globus Medical in Q3 2023 and held it in 1 quarter.
RFP Financial Group's Globus Medical position peaked at $2.04K in Q3 2023.
408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on RFP Financial Group's 13F filing for Q4 2023, filed 13 Feb 2024.